-
公开(公告)号:US11813272B2
公开(公告)日:2023-11-14
申请号:US16950120
申请日:2020-11-17
发明人: Steven John Taylor , John Robert Proudfoot , Mi-Jeong Kim , Kathleen Nudel , Timothy F. Briggs , Afrand Kamali Sarvestani , Leonard Buckbinder , Bernard Lanter , Ferdinand Edward Massari , Koji Yasuda , Spencer Cory Peck , Cheri Snedeker , Diana Le , Jessica Alexander , Anna Liang , Dinara Gunasekera , David Arthur Berry , John Patrick Casey, Jr.
IPC分类号: A61K31/7028 , A61P3/10 , A61K45/06
CPC分类号: A61K31/7028 , A61K45/06 , A61P3/10
摘要: Disclosed herein are active agents, compositions containing them, unit dosage forms containing them, and methods of their use, e.g., for treating a metabolic disorder or nonalcoholic fatty liver disease or for modulating a metabolic marker or nonalcoholic fatty liver disease marker.
-
公开(公告)号:US10953027B2
公开(公告)日:2021-03-23
申请号:US16803411
申请日:2020-02-27
发明人: Steven John Taylor , John Robert Proudfoot , Mi-Jeong Kim , Kathleen Nudel , Timothy F. Briggs , Afrand Kamali Sarvestani , Leonard Buckbinder , Bernard Lanter , Ferdinand Edward Massari , Koji Yasuda , Spencer Cory Peck , Cheri Snedeker , Diana Le , Jessica Alexander , Anna Liang , Dinara Gunasekera , David Arthur Berry , John Patrick Casey, Jr.
IPC分类号: A61K31/7028 , A61K45/06 , A61P3/10
摘要: Disclosed herein are active agents, compositions containing them, unit dosage forms containing them, and methods of their use, e.g., for treating a metabolic disorder or nonalcoholic fatty liver disease or for modulating a metabolic marker or nonalcoholic fatty liver disease marker.
-
3.
公开(公告)号:US12115178B2
公开(公告)日:2024-10-15
申请号:US17557772
申请日:2021-12-21
发明人: Steven John Taylor , Mi-Jeong Kim , Kathleen Nudel , Timothy F. Briggs , Koji Yasuda , Leonard Buckbinder , Bernard Lanter , Spencer Cory Peck , Cheri Snedeker , Angela She , Jessica Alexander , Anna Liang , Jenny Liu , Dinara Gunasekera , David Arthur Berry , John Patrick Casey, Jr. , Amir H. Moarefi
IPC分类号: A61K31/7036 , A61K9/00 , A61K31/191 , A61K31/196 , A61K31/353 , A61K31/519 , A61P37/06
CPC分类号: A61K31/7036 , A61K9/0053 , A61K31/191 , A61K31/196 , A61K31/353 , A61K31/519 , A61P37/06
摘要: Disclosed herein are acylated active agents and methods of their use, e.g., for modulating an autoimmunity marker or for treating an autoimmune disorder.
-
4.
公开(公告)号:US11058698B2
公开(公告)日:2021-07-13
申请号:US16803284
申请日:2020-02-27
发明人: Steven John Taylor , Mi-Jeong Kim , Kathleen Nudel , Timothy F. Briggs , Koji Yasuda , Leonard Buckbinder , Bernard Lanter , Spencer Cory Peck , Cheri Snedeker , Angela She , Jessica Alexander , Anna Liang , Jenny Liu , Dinara Gunasekera , David Arthur Berry , John Patrick Casey, Jr. , Amir H. Moarefi
IPC分类号: A61K31/7036 , A61K31/191 , A61K31/196 , A61K9/00 , A61P37/06 , A61K31/353 , A61K31/519
摘要: Disclosed herein are acylated active agents and methods of their use, e.g., for modulating an autoimmunity marker or for treating an autoimmune disorder.
-
-
-